Transcript Document

The Accelerator Fellowship Program: Alternate Career Paths for Graduate Students and Postdocs
Joshua K. McBee
The Institute for Systems Biology & Accelerator Corporation, Seattle WA.
What is Accelerator?
Accelerator is a biotechnology investment and
development company that specializes in the
creation early-stage biotechnology start-ups.
Accelerator takes a unique approach to the
creation of companies that minimizes risk in
the often volatile world of biotech start-ups.
By providing all resources necessary, risk and
overhead costs are reduced and dramatically
increases the chances of success for the
start-up.
Accelerator provides several
advantages to a start-up:
• Scientific Expertise from Accelerator and ISB
• Venture capital funding
• Management
• Infrastructure
Companies Created by Accelerator
Is using viral virulence factors to identify novel cellular targets for
immune modulation. Therapies directed against these targets
will treat a number of autoimmune and inflammatory disorders.
Develops tumor and pathogen specific therapeutic antibodies by isolation
of monoclonal antibodies from human tissue samples from prior exposed
patients
Incorporates unnatural amino acids into biological therapeutics to
Improve efficacy, tolerability, and pharmacology
Seredigm – Developing novel therapeutics to protect against tissue damage
in a number of acute or chronic medical conditions such as
ischemic reperfusion injury.
ReCodagen – Developing therapies against a novel target, MIG-7,
believed to play an important role in metastasis and invasion in
cancer.
Mirina – Using minor groove binding technology to develop antagonists against
What is the Accelerator Fellowship?
The ISB/Accelerator fellowship is a yearlong
training program for postdoctoral fellows,
graduate students, or research scientists at
the ISB who are interested in learning more
about entrepreneurial biotechnology and want
to become leaders in bringing next-generation
biotechnologies to market.
The fellowship allows you to spend 10% of
your time at Accelerator participating in the
decisions regarding scientific, business,
intellectual
property,
and
management
aspects of potential start-up companies. The
fellow has the opportunity to work and interact
with the Accelerator team as well as
experienced scientists and investors from the
Seattle biotech community and beyond. Many
of the connections the fellow makes will
become invaluable in their future career
decisions.
micro RNA’s (miRNA) for treatment of cancer, infectious diseases
or metabolic disorders.
Accelerator’s Investors
Accelerator has raised a total of $40.6 million for investment in
early-stage biotechnology. In all more than $140 million has been
invested in companies created by Accelerator.